James Italia PhD

Dr. James Italia, co-founder BrickBio’s proprietary chemistry, has joined the company as Vice President of Commercial Development. The company is building itself with both the key people in the industry, as well as around the technology itself. Dr. James Italia, Vice President of Commercial Development for BrickBio stated. “Our technology enables site-specific incorporation of one or more non-canonical amino acids into any protein, including antibodies, thereby significantly expanding its impact on the development of new therapeutics and diagnostics, as well as novel reagents for assays,” Italia continued.